Audience Discussion: Implementing Regulatory Strategies to Enable Post‑Approval Scale‑Out Without Compromising Product Quality
- Designing regulatory frameworks that support commercial‑scale manufacturing expansion, including site additions, tech transfer, and global footprint growth
- Aligning post‑approval change management with cost‑of‑goods reduction strategies, while maintaining comparability and regulatory confidence
- Ensuring consistent product quality across distributed clinical and manufacturing networks, using lifecycle management and data‑driven oversight models